MedPath

Penicillin G Benzathine

Generic Name
Penicillin G Benzathine

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
A-S Medication Solutions
50090-1666
INTRAMUSCULAR
600000 [iU] in 1 mL
9/12/2023
Dispensing Solutions, Inc.
68258-8910
INTRAMUSCULAR
600000 [iU] in 2 mL
10/29/2013
Pfizer Laboratories Div Pfizer Inc
60793-602
INTRAMUSCULAR
900000 [iU] in 2 mL
9/12/2023
Pfizer Laboratories Div Pfizer Inc
60793-702
INTRAMUSCULAR
2400000 [iU] in 4 mL
9/12/2023
Pfizer Laboratories Div Pfizer Inc
60793-600
INTRAMUSCULAR
600000 [iU] in 2 mL
9/12/2023
NuCare Pharmaceuticals,Inc.
68071-1824
INTRAMUSCULAR
1200000 [iU] in 2 mL
1/17/2024
Pfizer Laboratories Div Pfizer Inc
60793-701
INTRAMUSCULAR
1200000 [iU] in 2 mL
9/12/2023
Provepharm Inc.
81284-523
INTRAMUSCULAR
1200000 [iU] in 1 1
12/13/2023
A-S Medication Solutions
50090-1016
INTRAMUSCULAR
1200000 [iU] in 2 mL
9/12/2023
Pfizer Laboratories Div Pfizer Inc
60793-601
INTRAMUSCULAR
600000 [iU] in 2 mL
9/12/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
BICILLIN L-A
02291924
Suspension - Intramuscular
1200000 UNIT / 2 ML
6/11/2008
MEGACILLIN 500 SUS
merck frosst canada & cie, merck frosst canada & co.
00009938
Suspension - Oral
500000 UNIT / 5 ML
12/31/1961
MEGACILLIN 250 PEDI SUS
merck frosst canada & cie, merck frosst canada & co.
00107441
Suspension - Oral
250000 UNIT / 5 ML
12/31/1959
BICILLIN L-A INJECTION SUS 1200000IU/2ML
wyeth-ayerst canada inc.
02041596
Suspension - Intramuscular
1200000 UNIT / 2 ML
12/31/1994
BICILLIN A-P INJECTION PWS
wyeth-ayerst canada inc.
02041588
Powder For Solution - Intramuscular
600000 UNIT / 2 ML
12/31/1995

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.